Summary:
- This article discusses a new cholesterol-lowering pill that has shown promising results in clinical trials. The pill, called inclisiran, can reduce "bad" LDL cholesterol levels by up to 60%.
- Inclisiran works by targeting a specific gene that regulates cholesterol production in the liver, effectively reducing the amount of cholesterol in the body.
- The article notes that this new treatment could be a game-changer for people with high cholesterol, as it only needs to be taken twice a year, making it more convenient than daily statin medications.